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SUMMARY  
 
Astrocytes serve important roles that affect recruitment and function of neurons at the local and network 
levels. Here we review the contributions of astrocyte signaling to synaptic plasticity, neuronal network 
oscillations and memory function. The roles played by astrocytes are not fully understood, but astrocytes 
seem to contribute to memory consolidation and to mediate the effects of vigilance and arousal on 
memory performance. Understanding the role of astrocytes in cognitive processes may also advance our 
understanding of how these processes go awry in pathological conditions. Indeed, abnormal astrocytic 
signaling can cause or contribute to synaptic and network imbalances, leading to cognitive impairment. We 
discuss evidence for this from animal models of Alzheimer’s disease and multiple sclerosis, and from animal 
studies of sleep deprivation and drug abuse and addiction. Understanding the emerging roles of astrocytes 
in cognitive function and dysfunction will open up a large array of new therapeutic opportunities.  
INTRODUCTION  
Astrocytes are morphologically complex cells characterized by an intricate arborization and by anatomical 
specializations controlling local interactions with other CNS elements, including neuronal synapses, blood 
vessels and other glial cells. Each astrocyte occupies a brain territory distinct from that of other astrocytes, 
but together they can form dynamic networks via gap-junction connectivity. This anatomical complexity is 
mirrored by functional complexity. Astrocytes have been implicated in a variety of structural, metabolic and 
homeostatic functions, and in the control of cerebral blood flow. Since the ‘90s an additional astrocyte 
function has emerged  that has greatly contributed to our understanding of brain function at the cellular 
level, namely the interaction of astrocytes with synapses and neuronal circuits. Key initial observations 
were that astrocytes sense neuronal activity and respond to it with intracellular Ca2+ elevations and that 
they release transmitters in response to Ca2+ elevations and other stimuli. These observations gave rise to 
the concept of “tripartite synapses”1, in which astrocytes were for the first time considered as active 
participants in synaptic processing. 
Animal studies have shown that astrocyte interactions with synaptic circuits are multimodal and multiscale, 
occur under physiological conditions2-5 and contribute to behavior6-8. Astrocytes express a repertoire of 
receptors, transporters and other molecules enabling them to sense a multitude of synaptic mediators as 
well as cytokines, prostaglandins, and signals related to changes in local ionic concentrations, pH, immune 
or redox state. Moreover, astrocytes possess the machinery to produce a variety of molecules that can act 
at synapses, including glutamate, the NMDAR co-agonist D-serine, ATP and its catabolic product adenosine, 
metabolic agents such as L-lactate, and other soluble or contact factors that participate in the formation, 
stabilization, and elimination of synaptic connections3.       
Evidence of astrocyte-synapse communication exists in so many CNS circuits that it could be considered a 
universal contributor to synaptic functions. Recently, several rules governing this communication have 
started to emerge, dictated both by the specific biological properties of astrocytes and by the modalities of 
their dynamic interaction with individual synapses and neuronal networks. The astrocytic contributions 
appear to be circuit-specific9, stimulus-specific10, and their outputs in register with the modalities of their 
activation11. In parallel, improved Ca2+ imaging approaches have revealed a spatial-temporal diversity of 
astrocytic Ca2+ signals that may underlie the capacity of astrocytes to encode and process different patterns 
of activation, accounting for the above properties12, 13.   
In this review we discuss the role of astrocytes in cognitive processing, focusing on memory. To start, we 
will consider the lines of evidence that support a multimodal astrocytic involvement in local synaptic 
plasticity and in state-dependent oscillations of neuronal networks. Indeed, coordinated network 
oscillatory activity14 and plastic remodeling of the underlying synaptic circuits15 form the basis of memory 
encoding and other cognitive functions, which are influenced by brain states. We will then describe recent 
studies that more-directly demonstrate the involvement of astrocyte signaling in cognitive processing. 
Finally, we will discuss data showing that altered astrocyte-synapse/network function in pathological 
conditions contributes to cognitive disturbances.  
 
Astrocytes influence local synaptic activity and plasticity 
 
Astrocytes contribute to the functional outcome of local synaptic transmission and plasticity in at least two 
interrelated ways: they undergo plastic rearrangements in coordination with the pre- and post-synaptic 
elements (morphological plasticity), and they actively control synaptic function via exchange of regulatory 
signals with the synaptic (neuronal) elements (bi-directional communication).  
 
Morphological plasticity of astrocyte-synapse interactions  
Astrocytes have a role in regulating structural remodeling and functional plasticity of synapses. Crucial in 
this role are the perisynaptic astrocytic processes (PAPs), thin astrocytic lamellae surrounding synapses. 
PAPs express functionally relevant membrane proteins — such as glutamate transporters, which are 
essential for removing glutamate and terminating its synaptic actions — and contain the machinery for 
releasing fast transmitters2. PAPs ensheath synaptic elements to variable extents, depending on the brain 
area and circuit. For example, in the cerebellar cortex, PAPs of Bergmann glia (specialized cerebellar 
astrocytes) cover most synapses completely, whereas in the CA1 region of the hippocampus PAPs cover 
about half of the synapses and only partially16. The extent by which PAPs ensheath synapses is controlled 
by their actin-dependent motility and can change over time, including as function of neuronal activity (Fig. 
1). For example, extensive whisker stimulation enhances PAP ensheathment of dendritic spines in the 
mouse somatosensory cortex, and this effect is accompanied by changes in the location and efficacy of 
glutamate transporters17. By contrast, in the rat hypothalamic supraoptic nucleus during lactation PAPs 
retract from synapses, resulting in enhanced extrasynaptic glutamate leakage, reduced synaptic release 
probability and decreased availability of astrocyte-released D-serine for NMDA receptor activation. This 
leads to a modified glutamatergic input conveying suckling information to oxytocin neurons18. In the 
hippocampus, long-term potentiation (LTP) is associated with altered spatial relations between PAPs and 
synapses. During LTP induction, more PAPs become apposed to activated synapses19 — a form of local 
plasticity possibly supported by RNA translation within PAPs20. Real-time imaging shows that PAPs, due to 
actin remodeling, first increase their motility and subsequently enwrap the most enlarged spines more 
tightly 21, 22. In the amygdala, learning of the fear response produces a different plastic change, namely a 
decrease in the number of large synapses associated with a PAP23. Independently of the type of change, 
anatomical modifications of PAPs are not mere structural correlates of synaptic plasticity, but rather they 
are active parts of the plasticity mechanisms and can ultimately influence memory. For example, mice 
lacking the astrocyte gap-junction-related protein connexin-30 show increased PAP coverage of synapses, 
enhanced astrocytic glutamate uptake, reduced LTP expression and impaired fear memory24. Likewise, mice 
lacking the neuronal ephrin A4 receptor or its astrocytic ligand ephrin A3 show increased astrocytic GLT1 
glutamate transporter uptake and impaired hippocampal LTP25, paralleled by altered dendritic spine 
morphology26. In contrast, animals with genetically-reduced astrocyte calcium dynamics show reduced 
PAPs ensheathment of synapses, reduced glutamate clearance and increased NMDAR-mediated excitatory 
postsynaptic currents27; however, the role of astrocyte Ca2+ signaling needs further evaluation, because a 
different genetic interference strategy (see Table 1 for caveats on the two strategies) led to inconsistent 
results28. Together, these studies show that astrocytic and synaptic plastic changes occur coordinately and 
interdependently during synaptic remodeling. Rearrangement of the synaptic ensheathment modifies 
localization and efficacy of glutamate transport and astrocyte transmitter (gliotransmitter) release, thereby 
contributing to changes in the synaptic gain (Fig. 1).  
 
Astrocyte-synapse communication in synaptic plasticity  
Astrocytes contribute to synaptic plasticity by releasing fast mediators that directly modify synaptic 
function2, 4. This communication appears to play a critical role in various forms of plasticity (Fig. 2). For 
instance, classical NMDAR-dependent LTP at hippocampal CA1 synapses requires transient D-serine release 
from the astrocytes18, 29, 30. This D-serine “boost” appears to increase the occupancy of the NMDAR co-
agonist binding site (by about 20-25%) up to a threshold of activation, which then allows the receptor to 
trigger the downstream signaling pathway that underlies LTP induction. As D-serine may also be produced 
in neurons31, some authors have questioned an astrocytic D-serine contribution. However, a recent study 
showed that activation of astrocytic but not neuronal α7 nicotinic receptors boosts D-serine-mediated 
occupancy of the NMDAR co-agonist binding site32 (see below). Astrocyte-released D-serine participates 
also in another form of synaptic plasticity, namely the integration of adult-born granule neurons into the 
hippocampal circuitry33, a processes going on throughout life and influencing the local circuit performance 
in memory processes and mood control (reviewed in34). Thus, during synaptic integration, newborn granule 
neurons display a lower threshold for LTP induction and higher potentiation than mature neurons, thereby 
maintaining a high degree of network plasticity. The synaptic integration process requires vesicular release 
of D-serine from astrocytes. Thus, two transgenic mouse lines with selectively suppressed astrocytic 
release, dnSNARE35 and iBot mice36 (see Box and Table 1) showed defective integration of newborn granule 
cells, with delayed dendritic maturation and reduced excitatory transmission. In addition, the mice had 
reduced brain D-serine levels (also seen in derived astrocytic cultures), and application of exogenous D-
serine could restore synaptic integration and dendritic maturation of new neurons33.  
Another astrocyte-derived molecule, L-lactate, plays a key role in LTP at hippocampal CA1 synapses37. 
During high-energy demand, glycogen stored in astrocytes is metabolized to L-lactate and shuttled to 
neurons37, 38. Pharmacological inhibition of astrocytic glycogenolysis during LTP induction causes rapid 
decay of the synaptic potentiation — an effect rescued by co-injection of exogenous L-lactate37. Therefore, 
availability of L-lactate is necessary for maintaining LTP, although whether the agent acts as pure metabolic 
fuel for the synaptic remodeling or has additional functions is presently unclear. For example, L-Lactate can 
influence neuronal excitability in several ways, e.g. by boosting NMDAR activity and by stimulating other 
neuronal receptors, including the cell-surface lactate receptor GPR81 (reviewed in39-41). 
Astrocytes also influence synaptic plasticity via cannabinoid receptor type-1 (CB1) signaling (Fig. 2 and 4a). 
CB1R is highly expressed in the CNS (likely the most abundant GPCR)42, and much evidence has 
accumulated for a role of its natural ligands, the endocannabinoids (eCBs), in modulating synaptic function, 
such as via inhibition of transmitter release at GABAergic and glutamatergic terminals43. CB1Rs are also 
expressed  in astrocytes, although at lower levels than in neurons, and they participate in important 
mechanisms that regulate neuronal activity and ultimately memory performance4445, 46. Initial findings 
showed that activity-dependent eCB release from CA1 pyramidal neurons activated astrocytic CB1Rs, 
inducing astrocytic Ca2+ elevation and glutamate release, and resulting in NMDAR-dependent post-synaptic 
slow excitatory currents and mGluR1-dependent heterosynaptic facilitation of pre-synaptic glutamate 
release45, 46. Subsequent studies have shown that astrocyte CB1R signaling participates in long-term 
synaptic plasticity. Indeed, activation of astrocytic CB1Rs is necessary for induction of spike-timing 
dependent LTD (t-LTD) at L4-L2/3 cortical synapses, via glutamate release and activation of pre-synaptic 
NMDARs that permanently reduce synaptic transmission47. A recent study showed that the classical 
NMDAR-dependent LTP at CA1 hippocampal synapses requires (in addition to astrocyte D-serine29) 
astrocyte CB1Rs48, as their genetic deletion suppresses LTP, whereas supply of exogenous D-serine in the 
absence of the receptors restores it48. At the same synapses, astrocyte CB1Rs mediate glutamate-
dependent heterosynaptic LTP49, although they can also mediate t-LTD under specific spike-timing 
dependent induction protocols50.  
Astrocytes contribute also to synaptic modulation and plasticity associated with the activity of long-range 
cholinergic and noradrenergic fibers32, 51-55 (Fig. 2 and discussed below). Finally, astrocyte signaling to 
synapses appears to be regulated by immune mediators. Until recently, these molecules were thought to 
be produced mainly during pathological inflammatory reactions. However,  they are also present in the 
healthy brain, albeit at very low levels, and exert regulatory actions at synapses. For example, depending on 
the circuit, tumor necrosis factor-α (TNFα) can favor membrane insertion or internalization of AMPAR 
subunits at excitatory synapses56, 57. Through these effects, TNFα contributes to synaptic scaling, a form of 
homeostatic plasticity by which a population of synapses collectively adjusts its strength to long-term 
variations in network activity, e.g. during plastic rearrangement of sensory circuits58, 59. TNFα also affects 
synaptic strength through regulation of astrocyte glutamate release (Fig. 2 and 4c). In the hippocampal 
dentate gyrus, astrocytic stimulation transiently boosts excitatory synaptic transmission via glutamate 
release and downstream activation of stimulatory pre-synaptic NMDA receptors60. Constitutive levels of the 
cytokine are necessary and sufficient for the astrocytic input to be synaptically effective61. However, when 
TNFα levels increase in pathological conditions, the astrocytic input changes and causes long-lasting 
increase of synaptic strength62 (see below). Overall, astrocyte signaling via multiple surface receptor types 
and released transmitters contributes to the establishment of several forms of synaptic plasticity in various 
memory-relevant hippocampal and cortical circuits.  
 
Astrocytes sense brain states and modulate neuronal ensembles  
So far, we have discussed the involvement of astrocyte signaling in the plasticity of local synapses. 
However, cognitive functions emerge from more mesoscale processes involving coordinated activity of 
ensembles of neurons and synaptic circuits63. Neuronal network responses to external stimuli are regulated 
by brain states, and state-dependent excitability of neuronal networks is associated with specific cognitive 
functions. Neuromodulators, which produce spatially diffuse and slower effects than transmitters at fast 
excitatory or inhibitory synapses, are implicated in the generation of brain states. Intriguingly, 
neuromodulators’ actions involve activation of the astrocytic networks (Fig. 3a). Arousal, associated with 
activation of the locus coeruleus and widespread noradrenaline release, activates astrocytes in projection 
areas. This increases the responsiveness of astrocyte networks to local cortical activity64, suggesting that 
arousal increases the gain of such networks to perceive external stimuli and modulate neuronal function. 
Indeed, activation of astrocytic α1 receptors by noradrenaline triggers the release of D-serine and ATP, 
which facilitate LTP induction of layer 2/3 excitatory synapses in the somatosensory cortex 51. 
Acetylcholine, which is released during vigilance state by long-range cholinergic fibers (modulating 
attention and learning), also activates astrocyte networks and promotes astrocyte-mediated neuronal 
modulation32, 52, 53, 55, 65. Acetylcholine-activated astrocytes release D-serine at excitatory synapses, including 
at CA3-CA1 hippocampal synapses32 and somatosensory synapses53, to enhance NMDAR activity and 
NMDAR-dependent functions. Alternatively, they can release glutamate, which excites CA1 pyramidal 
neurons65 and inhibits dentate granule cells via intermediary GABAergic interneurons54. In addition, 
cholinergic input to astrocytes can induce LTP of glutamatergic transmission when cholinergic fibers and 
CA3-CA1 synapses are coincidentally active52.  
Both noradrenaline and acetylcholine regulate brain-wide oscillations, which are hallmarks of 
synchronization of different brain areas and are important for cognitive performance and sensory 
perception14. Interestingly, astrocytes have been recently reported to control neuronal oscillations in 
several ways (Fig. 3b). At the cortical level, they contribute to the generation of slow-wave oscillations (<1 
Hz), which occur prominently during NREM sleep and have been associated with memory consolidation66. 
These slow oscillations result in neuronal up- and down-states. Astrocytic Ca2+ signaling modulates up-state 
generation in situ67, whereas genetic suppression of gliotransmitter release reduces the power of slow-
wave oscillations in vivo68 (see below). Recently, studies using astrocyte-specific optogenetic stimulation 
have revealed a role for these cells in promoting the transition from high-frequency to low-frequency 
oscillatory states69. Stimulated astrocytes induce a localized increase in extracellular glutamate (likely glia-
derived) that increases co-active neuronal firing. Such astrocytic input acts as an instructive synchronizing 
signal for neuronal ensembles and triggers a switch of the cortical circuit to a slow-wave oscillation-
dominated state69 (Fig. 3b).  
Astrocytes modulate oscillatory patterns also in other frequency ranges, such as in the gamma range (25-80 
Hz). Both inhibitory and stimulatory effects have been reported in the hippocampus. The former was 
produced by optogenetic activation of astrocytes and involves coordinated control of pyramidal cell and 
CCK-positive interneuron excitability by astrocyte-released ATP/adenosine70. The latter was observed in 
mice with genetically-induced suppression of astrocytic exocytosis, which showed reduced EEG power in 
the gamma frequency range in vivo and this was associated with impairment of carbachol-induced gamma 
oscillations in vitro 71. The control of such network activity by glia likely depends on astrocytic stimulation 
by GABAergic interneurons, as astrocyte-specific GABAB knockout mice show reduced theta and gamma 
power in vivo72. Thus, sustained interneuron firing in the hippocampus induces astrocyte GABAB signaling, 
which triggers gliotransmission and thereby controls the oscillatory activity of the neuronal network72. 
Additionally, astrocytes contribute to the coordinated activity across brain regions, as mice with disrupted 
astrocytic exocytosis exhibit disordered hippocampal-prefrontal theta synchronization6.  
Astrocytes may mediate synchronization of neuronal ensembles in multiple ways. For instance, by releasing 
glutamate simultaneously onto several neighboring neurons and coordinately increasing their excitability 
via activation of extra-synaptic NMDAR73 and other glutamate receptors74. Importantly, direct dendritic 
recordings from hippocampal CA1 pyramidal neurons show that astrocytic glutamate does target neuronal 
dendrites and could be the source of dendritic plateau potentials75 implicated in localized plasticity and 
spatial memory formation76. Astrocytes can also release glutamate onto axons and their terminals, and 
thereby modulate axonal conduction, broaden action potentials74, or transiently increase presynaptic 
transmitter release46, 60, 77, 78. Since axonal/synaptic stimulation is a potent way to synchronize neurons, 
astrocytes may promote network coordination by acting simultaneously on many afferent fibers or 
synapses. In addition, they can extend their influence on neuronal domains by forming astrocytic domains 
via gap-junction connectivity. This astrocytic connectivity seems important for coordinating activation and 
for synchronizing bursting of the neuronal networks79. Overall, astrocytic signaling pathways emerge as 
relevant contributors to the generation and regulation of various network oscillatory rhythms and, by 
sustaining the action of neuromodulators, in tuning them according to brain states.  
 
Astrocyte signaling in memory processes and in the memory function of sleep   
Recent studies have linked astrocyte signaling at synaptic or network levels to cognitive performances in 
animals and have provided direct evidence that cognitive processing requires coordinated activity of 
synaptic ensembles and astrocytes. Consistent with this notion, chemogenetic activation of astrocytes in 
relevant circuits can affect memory performance7, 80. Gq-DREADD (Designer Receptor Exclusively Activated 
by a Designer Drug) activation in astrocytes of the medial central amygdala caused extinction of learned 
fear memory in a paradigm of cued fear conditioning80. The effect was ascribed to astrocyte-released 
adenosine reducing firing of medial central amygdala neurons by joint stimulation of the inhibitory inputs 
from lateral central amygdala (via A2A receptors) and inhibition of the excitatory inputs from basolateral 
amygdala (via A1 receptors). In another study, optogenetic and chemogenetic activation of the Gq 
astrocytic signaling pathway in the hippocampus were sufficient to enhance memory allocation and 
cognitive performance7. While these data showed that astrocytic activation can drive neuronal circuits to 
modulate memory performance, they did not prove yet that astrocytes are activated during physiological 
memory processes. However, studies using mouse genetics or pharmacological approaches to suppress 
specific signaling pathways exclusively in astrocytes provided such evidence (Fig. 4). A first study identified 
a necessary role for L-lactate in long-term episodic memory by pharmacological inhibition of its production 
in astrocytes37. The manipulation both suppressed CA3-CA1 LTP in vivo (see above) and impaired long-term 
memory formation in an inhibitory avoidance task, and these effects were rescued by administration of 
exogenous L-lactate37. The same impairment was produced by knock-down of the monocarboxylate 
transporters (MCTs) that shuttle L-lactate from astrocytes (MCT1 and MCT4) to neurons (MCT2)37. One of 
the neuronal functions requiring L-lactate is the de novo protein synthesis that maintains LTP and fosters 
memory consolidation37, 39, 81. More recently, noradrenaline acting on β2-adrenergic receptors was 
identified as one of the stimuli leading to L-lactate production during memory processing82, 83. 
Noradrenaline has long been known to potentiate LTP and hippocampal memory via β receptors, but the 
recent work has shown that relevant β2-adrenoceptors are expressed on astrocytes, not neurons (Fig. 2). 
Thus, astrocyte-specific knock-down of the receptors82 prevented memory consolidation, and this effect 
was rescued by local L-lactate supply in the hippocampus83. These data are significant because they link the 
known positive effect of arousal (and thus noradrenaline release) on memory performance to the finding 
that a key part of the noradrenergic effect is mediated by astrocytes. Similarly, noradrenaline release 
during acute stress activates astrocytic β2-adrenoceptors receptors84.  Stress stimuli can both enhance and 
decrease cognitive performance depending on their severity and duration, and it is possible that this 
distinction may reflect  the duration and extent of astrocyte activation by during stress. A recent study 
showed that administration of a β2 agonist over days improves memory performance by up-regulating the 
astrocytic L-lactate export pathway, whereas with longer applications the drug causes internalization of β2-
adrenoceptors and decreases cognitive ability, likely by reducing astrocytic L-lactate supply to neurons84.   
Astrocytes also participate in hippocampus-dependent memory formation by controlling the availability of 
D-serine for synaptic NMDAR activation7, 32, 48 (see above). At least two distinct astrocytic pathways 
promote this effect, one engaging α7 nicotinic receptors32, the other CB1 receptors48. The first pathway 
depends on the state of vigilance and is mediated by activation of septal cholinergic fibers (see above), 
which in turn stimulate α7 receptors on hippocampal astrocytes (and not in neurons) to promote D-serine 
release, thereby boosting NMDAR activation at CA3-CA1 synapses32. Indeed, NMDAR co-agonist site 
occupancy positively correlated with D-serine levels dictated by the wake/sleep cycle, being maximal during 
wakefulness (dark period for mice). This astrocyte-dependent control of D-serine release had behavioral 
consequences, as the strength of fear memory in a contextual fear-conditioning task was higher in dark 
than in light periods32, suggesting that astrocytes may convey the vigilance input to enhance memory 
performance (Fig. 3a). In the second pathway, signaling via astrocyte CB1 receptors affects hippocampus-
dependent memory by boosting D-serine-mediated NMDAR activation at CA3-CA1 synapses (Fig. 4a). 
Deletion of astrocytic CB1 receptors reduced NMDAR co-agonist binding site occupancy, suppressed CA1 
LTP in vivo (see above) and impaired recognition memory; these effects were rescued by administration of 
exogenous D-serine or pharmacological blockade of D-serine catabolism48. Importantly, exogenous D-serine 
was effective when administered immediately after memory acquisition but not 1 hour later, indicating 
that astrocyte CB1 signaling is engaged in the early phase of memory consolidation48. Accordingly, 
astrocyte-specific optogenetic activation of a light-sensitive Gq-coupled receptor (OptoGq) increased 
memory acquisition only during the learning phase7.  
Another study confirmed the role of astrocyte signaling in recognition memory71. In transgenic mice with 
inducible tetanus toxin expression selectively in astrocytes (Table 1), the resulting suppression of astrocytic 
exocytosis impaired both gamma frequency oscillations in vivo (see above) and performance in the novel 
object recognition task. Both effects were reversed by stopping tetanus toxin expression in astrocytes71. 
Similarly, dnSNARE transgenic mice lacking regulated exocytosis in astrocytes display both altered 
hippocampal/prefrontal synchronization and defective spatial learning and reference memory6. 
Astrocytes also contribute to the memory function of sleep. Sleep promotes memory consolidation 
(reviewed in85), particularly during early night NREM phases, which are rich in cortical slow-wave 
oscillations. This consolidation refines memory engrams by establishing long-lasting forms of synaptic 
potentiation (L-LTP) for memories to be retained, while simultaneously reducing less-relevant memories via 
synaptic depression and downscaling of established synapses86, 87. Sleep deprivation impairs memory 
consolidation by interfering with the above processes. During prolonged wakefulness the need to sleep 
increases due to progressive increase in the levels of adenosine, a sleep-inducing molecule (reviewed in88). 
If the wake period is excessively long, adenosine levels in the following sleep period decay slower than 
normal. Adenosine was long believed to be produced by neurons, but recent work35 using dnSNARE 
transgenic mice challenged this idea and suggested instead an astrocytic origin. These mice lack regulated 
exocytosis in astrocytes35, including release of the adenosine precursor ATP89 (see above; see Table 1 and 
Box 1 for a discussion on the model validity). When sleep-deprived, dnSNARE mice showed no adenosine 
accumulation, as measured in hippocampal slices90, and exhibited much milder phenotypes than control 
mice, with little alteration of slow-wave cortical oscillations and cognitive performance91, 92. Therefore, 
astrocyte-released adenosine  may underlie impaired cognitive function upon sleep deprivation.  
A recent study showed that another astrocyte-released molecule, L-lactate, has the opposite role to 
adenosine, helping maintain normal sleep architecture and, therefore, preserving cognitive performance by 
supporting the activity of wake-producing orexin neurons in the lateral hypothalamus40. Overall, studies 
involving selective activation or suppression of given astrocytic signaling pathways have revealed 
participation of astrocytes to specific types or phases of memory processes. Likewise, astrocyte signaling 
has a role in the memory function of sleep as well as in the detrimental consequences of sleep deprivation.  
 
Astrocytic control of cognitive function goes awry in pathological brain conditions 
The role of astrocytes in synaptic and network processing appears to be plastic and subject to 
perturbations. In pathological conditions, astrocyte-neuron interactions can undergo dramatic changes, 
with strong impact on brain circuits supporting memory formation and cognitive function. This is the case in 
Alzheimer’s disease (AD), a pathology characterized by progressive impairment of memory and other 
cognitive functions such as abstract thinking, judgment, language, and recognition. The notion that 
astrocytes surrounding β-amyloid (Aβ) deposits are altered in AD stems from the original description of AD 
pathology by Alois Alzheimer in 1911. Only recently have the anatomical descriptions been complemented 
by functional studies. These studies showed an increased expression of several receptors in astrocytes 
surrounding Aβ sites in both AD mouse models and post-mortem human AD brains, likely affecting the 
downstream signaling and its synaptic function93. Up-regulated receptors included α7 nicotinic Ach 
receptors94, Ca2+-permeant ligand-gated channels whose up-regulation causes abnormal astrocytic Ca2+ 
elevations and massive glutamate release95, 96; mGlu5 receptors97 and P2Y1 receptors98, whose  enhanced 
Gq-IP3-dependent Ca2+ signaling can similarly contribute to astrocytic Ca2+ alteration; A2A adenosine 
receptors99, which instead signal via Gs-cAMP. A2A receptors normally promote “active forgetting”, a 
process that removes irrelevant memories during sleep100. However, when excessively activated in AD99, A2A 
receptors may accentuate the “forgetting pathway” resulting in reduced memory performance. In line with 
this, transgenic mice lacking the A2A receptor or AD mice treated with an A2A antagonist101 show increased 
memory (but see102), whereas mice in which astrocyte Gs signaling is selectively stimulated (Table 1) show 
the opposite99. Another signaling aberration seen in reactive astrocytes surrounding Aβ deposits consists in 
an enhanced synthesis and release of the transmitter GABA103-105, which increases tonic inhibition of 
dentate granule cells with a negative impact on memory processing.  
AD patients and AD mouse models display excitation/inhibition circuit imbalances that affect the oscillatory 
patterns underlying cognitive processing106, 107. In mouse models, neurons within the vicinity of Aβ 
deposition are often hyperexcitable, possibly due to an altered local microenvironment. This could be 
explained by Aβ-mediated disruptions of glutamate uptake108, glutamate release109 and GABAergic 
inhibition110. Interestingly, astrocytes in apposition to Aβ deposits are also “hyperactive” and display higher 
resting Ca2+ level, more frequent and larger Ca2+ elevations, long-range coordinated Ca2+ waves that are 
never seen in control mice95, 98, 111, as well as increased gliotranmission112. These abnormalities could be due 
to a direct action of Aβ on astrocytes 113 as well as enhanced receptor-mediated Ca2+ signaling (see above) 
and are likely to affect the neuronal network, e.g. by extending the areas of functional alteration and 
abnormal synchronization. Preventing excessive Ca2+ increase/transmitter release from astrocytes might 
therefore represent a promising strategy for AD therapy. In keeping with this idea, the acetylcholinesterase 
inhibitor donepezil, which is approved for symptomatic AD treatment, appears to reduce astrocyte Ca2+ 
signaling114. Moreover, P2Y1R antagonists or genetic suppression of IP3R2-dependent astrocyte Ca2+ 
signaling reduce neuron-astrocyte network hyperactivity and ameliorate spatial learning and memory 
deficits in AD mice115.  
AD, along with many other CNS pathologies, is characterized by the presence of local intra-parenchymal 
inflammation. It has been proposed that astrocytic modulation of network activity and cognition undergo 
deleterious transformation in such inflammatory states. An example of this was observed in the 
experimental autoimmune encephalitis (EAE) model of multiple sclerosis, where abnormal TNFα-
dependent signaling by astrocytes causes cognitive deficits resembling those seen in patients62 (Fig. 4d). In 
particular, in EAE mice, a local inflammatory focus in dorsal hippocampus caused TNFα increases, long-
lasting modification of excitatory neurotransmission and impaired contextual memory. These effects 
depend on enhanced TNFα signaling via its astrocytic type-1 receptor (TNFR1), which hijacked the 
regulatory mechanism controlling astrocytic glutamate release (see above) and caused long-lasting 
potentiation of excitatory synapses. This synaptic and behavioral phenotype was abolished in global TNFR1 
knockout EAE mice and could be restored by inducing re-expression of the receptor solely in astrocytes 
(Table 1), demonstrating that astrocytes mediate the deleterious action of TNFα on memory function in 
EAE mice62.  
Based on the role of TNFα in promoting inflammation-induced memory impairment, significant efforts have 
aimed to develop TNFα inhibitors for treating CNS diseases. Several such agents have been, or are currently 
being, tested for disorders including multiple sclerosis and AD, with both success and failures having been 
reported58. Selective blockade of TNFR1 function may be a more promising therapeutic strategy with 
increased mechanistic specificity116. Accordingly, new TNFR1 antagonists with CNS action were effective in 
reversing enhanced glutamatergic transmission in an AD mouse model117. 
Recently, astrocytes have been implicated in the development of drug addiction. The astrocytic role in 
addiction appears to involve altered D-serine and L-lactate signaling which in turn perturbs physiological 
synaptic plasticity and memory. Hence, instalment of the addictive behavior occurs via formation of 
“maladaptive memories” in the mesocorticolimbic reward circuitry - ventral tegmental area (VTA) and 
nucleus accumbens (NAc) - that take over the normal memory processes activated by natural rewards. For 
example, cocaine alters glutamatergic function in the NAc by modifying the AMPAR/NMDAR currents ratio 
and by impairing LTP and LTD118. As astrocytes influence glutamatergic transmission in the NAc118, 119, they 
could participate in these changes. Consistently, cocaine treatment leads to reduced D-serine levels in the 
NAc, which could explain the reduced NMDAR-dependent synaptic plasticity associated with cocaine 
treatment (both LTP and LTD119, 120). In keeping, exogenous D-serine treatment reverts the impaired 
plasticity and reduces a number of behavioral manifestations associated to cocaine addiction, including  
cocaine-induced place preference121, 122, reinstatement of cocaine self-administration (relapse)123 and 
locomotor sensitization to cocaine120, 121. Furthermore, the fact that D-serine treatment can reduce 
compulsive alcohol intake124 and that D-serine participates in the mechanisms of morphine addiction125 
suggests a role for altered D-serine signaling in the establishment of addictive behavior at large. Therefore, 
compounds acting on D-serine metabolism hold promise for the treatment of addictions118. Astrocyte 
signaling via L-lactate appears likewise involved in the formation of maladaptive memories and 
reinstatement of drug addiction. Accordingly, pharmacological inhibition of astrocyte L-lactate release 
prevents cocaine relapse by persistently disrupting cocaine-induced conditioned place preference126, 127. 
Cannabis-induced disruption of working memory also appears to be astrocyte-mediated (Fig. 4b). 
Specifically, systemic treatment with ∆9-tetrahydrocannabinol (THC, the main active compound of 
marijuana), causes LTD of CA3-CA1 hippocampal synapses and impaired working memory in vivo44. 
Strikingly, parallel tests conducted on astrocyte-specific and neuron-specific CB1R knock-out mice (Table 1) 
demonstrated that astrocytic, not neuronal, CB1Rs are essential mediators of both the plasticity and 
behavioral memory effects of THC44. These findings demonstrate not only that astrocyte-dependent LTD 
underlies THC-induced working memory impairment, but also that THC “hijacks” the astrocyte CB1 
signaling pathway normally involved in CA3-CA1 LTP and memory formation48. 
In summary, various astrocytic signaling pathways, some of which with recently identified roles in synaptic, 
network and memory functions, undergo profound changes in CNS disorders characterized by cognitive 
alterations. Their mechanistic contributions to specific conditions start to be unraveled, notably via mouse 
genetics studies.  
 
CONCLUSIONS 
We here presented evidence that astrocytes are actively involved in normal memory functions as well as in 
the abnormal processes leading to cognitive impairment in pathological conditions. In many of the 
presented cases, our understanding of the astrocytic involvement is still incomplete and more work is 
required to confirm these findings and better elucidate the specific role played by astrocytes and the 
precise targets and mechanisms of their action. The notion that astrocytes integrate neuronal function at 
synaptic and network levels to influence behavior is rather new, particularly because these cells have long 
been thought to be largely unable of communication and computing. Only recent findings using state-of-
the-art approaches with an ad hoc design to study astrocytes paint a different picture. For example, 
dynamic cellular imaging work12, 13 reveals an unexpected functional complexity of astrocytes and an 
intimacy of their interactions with neurons, while astrocyte-targeted mouse genetics boosts the case for 
astrocyte participation in memory processes, as reviewed here. While leading to these breakthroughs, the 
technical advances also highlight the incompleteness of our comprehension of astrocyte biology, illustrated 
also by numerous ongoing controversies in the field2, 4, 5. This calls for development of even better 
astrocyte-specific investigation tools, techniques, and experimental designs to resolve these controversies 
and bridge the current gap of knowledge.  
How may astrocyte interactions with synapses and networks influence neuronal activity and memory 
performance? Considering the spatial-temporal properties of astrocyte signaling as we currently 
understand them, there appear to be at least four possible spatial scales of interaction (Fig. 5): first, a 
nanoscale, at which astrocytes signal in “nanodomains” and may influence local synaptic computations and 
remodeling1, 12, 21, 77, 128; second, a microscale, on the order of a single astrocyte, at which the entire cell 
activates and may exert a coordinated influence on synaptic ensembles residing in its territory29, 129; third, a 
syncytium scale, at which groups of astrocytes form, via dynamic gap-junction connectivity, functional 
domains matching domains of neuronal activity and may coordinate the excitability and support the 
energetic demands of the functional neuronal ensembles40, 79; and fourth, a mesoscale, at which astrocytes 
from multiple brain regions respond in concert to the activity of long-range neuronal fibers and may 
thereby contribute to the generation of brain states. At the temporal scale, astrocytes are currently 
thought to be unable to modulate synapses at the time scale of synaptic events, and instead are thought to 
exert slower influences, by tuning basal synaptic properties like transmitter release probability77, 128 and 
post-synaptic excitability (Fig. 5a)2, 73. These slow temporal properties of astrocytes could be essential 
during induction of synaptic plasticity, for maintaining the history of past activity and to initiate plastic 
changes47. Intuitively, a multiscale spatial-temporal astrocytic integration with the neuronal network should 
produce a higher-order organization of the information processing130. This is what computational models 
predict, i.e. that  integration of astrocytes improves network performance131. In particular, astrocytes 
would increase firing synchronicity and synaptic coordination132, and better tune the networks to oscillatory 
rhythms underlying memory processing133.  
Specific roles of astrocytes are currently largely speculative. For example, requirement for L-Lactate during 
long-term memory consolidation could be in support of the “extra” metabolic needs of the structural 
remodeling involved in this process. This way, the active metabolic function of astrocytes would be an 
integral element of brain cognitive function41. The fact that L-lactate cannot be substituted in this function 
by equicaloric glucose37 hints, however, at additional non-metabolic functions for this molecule. The need 
for D-serine in the early phases of memory formation and the fact that, by controlling its availability, 
astrocytes control synaptic NMDAR function according to the sleep/wake cycle, suggests that astrocytes 
link vigilance state to memory formation. The same may apply to their activation during arousal, which is 
known to enhance cognitive performance. Along this line, astrocytes might use cytokine signaling to tune 
cognitive processing to immune states and, even further, by integrating non-neuronal inputs and checking 
metabolic, redox, pH, immune or other environmental states, astrocytes could perform their own 
computations, eventually resulting in instructive signals sent to neurons. 
Integration of astrocytic signaling in cognitive processing has implications for understanding the basis of 
cognitive alterations in pathological conditions. We presented several examples in which altered astrocytic 
signaling affects synapses, networks and ultimately cognitive performance. These findings suggest that 
targeting astrocyte pathways may represent an important new therapeutic opportunity to fight against 
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Figure legends  
 
Fig. 1 Plasticity of structural interactions between synaptic elements and perisynaptic astrocytic 
processes (PAPs).  Left: a reduced PAP coverage of synapses, such as occurs in the supraoptic nucleus 
during lactation18, increases glutamate leakage from the synaptic cleft and reduces D-serine availability in 
the vicinity of the postsynaptic NMDA receptors. Less D-serine in the synaptic cleft reduces the activation 
of the NMDA receptors and increases the threshold for LTP induction18.  Right: An extensive PAP coverage, 
such as induced by connexin-3024 or ephrin-425 knockout, enhances the PAP’s reuptake of glutamate, 
which reduces the neurotransmitter availability in the synaptic cleft and impairs LTP expression.  
 
Fig. 2 Bidirectional signaling between synaptic elements and PAPs controls synaptic function and 
plasticity. For graphical clarity, the bidirectional signaling is depicted as involving in part the top PAP and in 
part the bottom PAP. Activity-dependent release of endocannabinoids (eCB) from post-synaptic neurons 
stimulates both pre-synaptic and astrocytic cannabinoid 1 receptors (CB1Rs). Activation of pre-synaptic 
CB1R exerts an inhibitory effect on synaptic transmitter release, whereas activation of astrocytic CB1R 
induces release of glutamate (red dots, top and bottom PAP) and/or D-serine (yellow dots, top PAP). 
Astrocyte glutamate modulates synaptic transmission and plasticity by activating pre-synaptic mGluRs, pre-
synaptic NMDAR, as well as dendritic (extra-synaptic) NMDARs. Depending on the circuit, the effect can be 
stimulatory or inhibitory9, 45-50. Astrocyte D-serine potentiates post-synaptic NMDAR activation18, 29, 30, 32 and 
increases the synaptic integration of new neurons generated in the adult hippocampus33. Activation of 
cholinergic (top PAP), purinergic and noradrenergic (bottom PAP) receptors on astrocytes induces release 
of fast-acting molecules that influence synaptic activity and plasticity via both pre- and post-synaptic 
mechanisms. In particular, activation of nicotinic α7 or muscarinic receptors by acetylcholine (Ach) induces, 
respectively, D-serine32 and glutamate release52, 65 with stimulatory synaptic effects mediated by post-
synaptic NMDAR (D-serine) and pre-synaptic mGluR (glutamate). Activation of purinergic P2Y1 receptors by 
ATP induces glutamate release and activation of stimulatory pre-synaptic NMDAR. The P2Y1R-evoked 
glutamate release is controlled by TNFα via TNFR1 signaling61 (see also Fig. 4). Activation of β2 
adrenoceptors by noradrenaline (NA) increases astrocytic glycogenolysis and production of L-lactate and its 
shuttling out of the cell by monocarboxylate transporters (MCT)-1 or 4. L-lactate can enter the neurons via 
MCT2 or act on putative membrane receptors37, 82, 83, inducing metabolic and/or signaling effects possibly 
involving control of NMDAR function.  
 
Fig. 3 Astrocytes modulate neuronal network oscillations and contribute to memory performance. a. 
Astrocytes stimulated by acetylcholine (during vigilance) 27, 32, 52, 65  or noradrenaline (during arousal)64 are 
primed by the brain state and contribute to functional changes such as long-term plasticity of synaptic 
networks and enhanced memory performance 51, 82, 83. The noradrenergic input from locus coeruleus 
increases astrocyte responsiveness to local circuit activity in the cortex64 whereas the septal cholinergic 
input boosts hippocampal memory through astrocyte activation32. Activated astrocytes depicted in green. 
b. Activation of astrocytes drives coordination of the activity of neuronal networks and their switch from 
desynchronized to oscillatory states, including slow-wave oscillations that are important for memory 
consolidation67-69 and gamma oscillations that enhance recognition memory70-72. Activated astrocytes 
depicted in green; desyncronized neurons depicted in different colors corresponding to the different times 
of their firing; synchronous-firing neurons all depicted in orange, corresponding to their oscillatory up-
states.  
 
Fig. 4: Effects of astrocyte signaling on hippocampus-dependent memory pathways in physiological and 
pathological conditions  
a. During the induction of long- term synaptic potentiation (LTP) via high-frequency stimulation at CA3-CA1 
synapses (1,2),  endocannabinoids (eCB) are released in an activity-dependent manner from postsynaptic  
neurons (3). eCB activate CB1 receptors (CB1R) on astrocytes (4) and induce D-serine release (5), which is 
necessary for NMDAR-dependent LTP of the synapses (6)48. Appropriate recognition memory performance 
requires such astrocyte signaling48. b. In a pathology-related setting, injection of THC, the major 
cannabinoid component of marijuana, causes activation of astrocyte CB1Rs (1), but in this case the 
downstream signaling activated is different and leads to LTD of CA3-CA1 synapses and impaired working 
memory44. This effect seems to involve astrocyte glutamate release (2), activation of extrasynaptic NR2B-
containing NMDARs (3) and, eventually, internalization of AMPAR (4). c. Astrocytes control synaptic 
transmitter release probability at perforant path-granule cell synapses in the dentate gyrus61, a key 
pathway for context discrimination. Activity of these excitatory synapses leads to stimulation of purinergic 
P2Y1 receptors (P2Y1R) on astrocytes (possibly by synaptically co-released ATP) (1), which induce 
glutamate release (2) via a processes controlled by constitutive TNFα signaling via TNFR1 (1). Astrocytic 
glutamate acts on pre-synaptic NR2B-containing NMDAR (3) to transiently up-regulate synaptic transmitter 
release (4) and increase frequency of AMPAR-mediated synaptic events (5)60. Studies in TNFα and TNFR1 
knockout mice indicate that cytokine signaling is necessary for appropriate hippocampus-dependent 
memory58. d, During brain inflammation, however, massive increase in TNFα released by activated 
microglia and/or infiltrated immune cells and overstimulation of astrocyte TNFR1 (1) leads to excess 
glutamate release (even in the absence of P2Y1R stimulation) (2), pre-synaptic NMDAR activation (3). The 
final effect is a long-lasting enhancement of synaptic transmitter release (4) resulting in impaired 
contextual memory62. 
 
Fig. 5 Multiscale spatial-temporal integration of astrocytes with synaptic and neuronal networks. a. 
Communication between neurons and astrocytes occurs on temporal scales (secs to min) distinct from 
neuronal firing and fast excitatory or inhibitory synaptic transmission (msec) and likely serves different 
functions, such as tuning synaptic outputs, inducing long-term changes in synaptic gain, promoting network 
synchronicity. b. At the spatial nanoscale, local signaling in astrocytic PAPs can target pre-synaptic terminals 
to change synaptic transmitter release probability, or post-synaptic ones, to change neuronal excitability. c. 
At the microscale level, an individual active astrocyte can affect coordinately multiple synapses sitting in its 
territory (different colors denote that synapses belong to different neurons), e.g. by simultaneous multi-site 
release of modulatory transmitters. d. At a syncytium scale, groups of astrocytes can form dynamic 
networks via gap-junction connectivity (green) to match domains of highly active neurons (orange) and 
support or regulate their function. e. At the mesoscale level, populations of astrocytes in different brain 
areas can respond in concert to activity of long-range neuronal projections, such as noradrenergic fibers 




Table 1: List of mouse lines that target astrocytes, highlighting their caveats and strategies used 
to circumvent them 
Driver Full construct Gene manipulation Comments References 
None 
IP3R2 -/- 
Constitutive ubiquitous ablation of 
IP3R2 and lack of downstream Ca2+ 
signaling 
A full KO may induce compensations. IP3R2 KO does 
not block thapsigargin-induced Ca2+ rise. The 
efficiency at blocking Ca2+ rises has not been 
examined in fine, perisynaptic processes in which 
recent work suggests the presence of additional 
sources of Ca2+ elevation4. The potential presence and 
role of IP3R2 in non-astrocytic cells has not been 
evaluated 
27, 52, 134 
GFAP-Srr 
Overexpression of serine racemase 
in GFAP+ cells  
Same comments as above. Serine racemase is 
involved in the biosynthesis of other D-amino acids, 




GFAP-Cre Lack of IP3R2-dependent Ca++ 
signaling or of A2A receptor in 
astrocytes 
The construct does not enable a time control of the 
recombination. Therefore, recombination may be 
expected in neurons. The absence of recombination 
in neurons was evaluated by immunofluorescence In 
99, and by PCR on FACS-sorted cells in 102 
28, 99, 102, 136 
x 




Lack of ß2-adrenergic receptors, 
GluA1 and GluA4 subunits of AMPA 
receptors, or GABAb receptors 
The efficiency of the inducible KO approach was 
assessed by qPCR on sorted astrocytes 82, 
electrophysiology and immunohistochemistry 137and 
the absence of recombination in neurons was verified 
by electrophysiology in 72 








Lack of cannabinoid CB1R in 
astrocytes 
The deletion of CB1R in astrocytes and the absence of 
recombination in neurons were confirmed by 
immuno-electron microscopy. The deletion of CB1R in 
neurons did not induce a phenotype, supporting the 






TNFR1 knockout with inducible re-
expression of the receptor in 
astrocytes 
The specificity of the construct for astrocytes was 
examined with immunofluorescence and PCR. Only 
about 0.7 % of recombined cells in the dentate gyrus 
were neurons, originating from endogenous GFAP-






Suppression of serine racemase in 
astrocytes 
No reporter was used, so the number of targeted 
astrocytes is unknown. Neuronal or astrocytic knock 
out of serine racemace did not reduce D-serine brain 







Expression of a Botulinum toxin 
isoform blocking secretion in 
astrocytes 
The authors33 found similar effects of dnSNARE mouse 
(below) and iBOT mouse on adult neurogenesis. 
Furthermore, the effect of transgene expression on 
synapse formation was locally restricted to transgene-
expressing astrocytes,  confirming the astrocytic 





GFAP-tTA Stimulation of Gq-GPCR signaling in 
astrocytes 
The specific expression in astrocytes was verified by 
immunofluorescence. Long Ca2+ events have been 
assessed in the soma and processes, but it is unclear 
whether the construct enables fast local Ca2+ 
dynamics in fine processes and gliapil as observed 





x Chemogenetic activation of 
astrocyte Gs-coupled signaling 
The specific expression in astrocytes was verified by 
immunofluorescence. About 12% of astrocytes 
express the synthetic Gs protein.  tetO-Rs1 
GLT1-tTA- Attenuation of IP3-dependent Ca++ 
signaling in astrocytes 
Animals of this study were never treated with 
doxycycline, which induced constitutive transgene 
expression with possible compensation. Due to the 
expression of the GFAP promoter in neuroblasts, a 
residual sponge expression in immature neurons is 







GFAP-tTA Expression of a dominant negative 
VAMP2  that suppresses regulated 
secretion in astrocytes 
Results from Ref139 suggest possible transgene mRNA 
transcription in immature neurons, although the 
effect of this low transcription has not been assessed 
on protein expression, neither on vesicular release. 
See box 1 text above for further discussion. 
32, 35, 68, 91, 
92, 139 x 
tetO-dnSNARE 
tTA/tetO     
and        
CreERT2 
GFAP-tTA Inducible and reversible expression 
of Tetanus toxin blocking secretion 
in astrocytes 
The block of glutamate exocytosis from astrocytes 











               
  
Box 1 – Genetic models to study astrocyte signaling in memory processes 
Several mouse models have been used to address the contribution of astrocyte signaling to memory 
processes. For the simplest models, such as the widely used IP3R2 knockout mice138, the astrocyte-
specificity relies on the assumption that the protein is expressed exclusively in astrocytes. This assumption 
requires convincing evidence, including a demonstration of differential expression of the protein in 
astrocytes versus other CNS cell populations140, 141. More specific models are based on strong, astrocyte-
specific promoters and controllable transgene expression.  
A number of promoters such as hGFAP, GLAST, GLT1, CX43 and FGF3, are considered selectively active in 
astrocytes142. However, their efficiency can vary greatly between astrocytes and between brain regions143 
and it can be useful to verify their expression for the defined CNS area (for example using reporters such as 
GFP) and animal age of interest. Promising in this respect is the recent availability of the AldH1L1 promoter, 
which seems to have widespread CNS efficiency144, 145. Another critical aspect of these promoters is that 
most of them are active in neural stem cells and therefore, astrocyte-specificity is only guaranteed after 
development, when stem cells have evolved into their mature progenies. 
With regard to controllable transgene expression, both the CreERT2/loxp146, 147 and the tTA/tetO systems148 
provide temporal control of gene manipulation, which is necessary to overcome the developmental issue. 
However, gene manipulation may still occur in adult neural stem cells in the sub-granular zone of the 
hippocampus and the sub-ventricular zone. Consequently, validation of an astrocyte-dependent phenotype 
in an area that sustains adult neurogenesis requires careful controls, for example by using a coherent 
timing between transgene expression and phenotype62. In the future, a better understanding of gene 
expression in adult neural stem cells will enable the use of astrocytic promoters that are not expressed in 
the precursor cell population149. In contrast, in non-neurogenic brain areas, the CreERT2 system driven by 
an astrocytic promoter143, 150 of verified specificity is highly reliable, and cognitive phenotypes described in 
these areas can be attributed to astrocyte signaling. The tTA/tetO system resembles the CreERT2/LoxP 
system in allowing for inducible gene manipulation, with the disadvantage of a slower time-course and the 
advantage of a reversible effect. This is the system used to create the dnSNARE mouse model35. Although 
this model has been recently criticized139 based on a reported leakage of dnSNARE expression in neurons, 
several other studies have not observed this leakage32, 33, 89. Further, the dnSNARE mouse colonies used in 
the critical study139 were different from those used by the other groups, who all relied on the colony 
originally described35. It is therefore possible that a divergence occurred between colonies, a known and 
serious problem in mouse genetics.  
Regardless of the strategy, the timing of the experiments is also important. For example, protein knockout 
is efficiently achieved when not only de-novo synthesis of the protein of interest is abolished but also 
degradation of the existing protein is complete137. 
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